Talphera, Inc. (TLPH)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 28,000
- Net income
- -14,290,000
- Operating income
- -13,484,000
- Earnings per share
- -0.34
- R&D expense
- 6,033,000
Growth and profitability
- Operating margin
- -48,157.14
- Net margin
- -51,035.71
- Return on equity
- -83.89
- Return on assets
- -48.08
Balance sheet
- Total assets
- 29,719,000
- Total liabilities
- 12,684,000
- Shareholders' equity
- 17,035,000
- Cash and equivalents
- 5,894,000
- Current ratio
- 5.49
Cash flow and ratios
- Operating cash flow
- -11,364,000
Shareholder returns
- Shares outstanding
- 51,957,714
- Book value per share
- 0.33
Company information
- Headquarters
- San Mateo, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Talphera, Inc. trades on NASDAQ under the ticker symbol TLPH. This page brings together its price chart, company profile, key financial figures and technical indicators.